Tofacitinib;fingolimod hydrochloride
- Generic Name
- Tofacitinib;fingolimod hydrochloride
Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2022-08-31
- Lead Sponsor
- Vyne Therapeutics Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT04927572
- Locations
- 🇺🇸
Investigator #14, Miami, Florida, United States
🇺🇸Investigator #9, Miami, Florida, United States
🇦🇺Investigational Site #1, Adelaide, South Australia, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath